Ultragenyx Pharmaceutical reported $15.19M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Biocryst Pharmaceuticals BCRX:US $ 13.66M 3.82M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Bluebird Bio BLUE:US $ 0.77M 12.74M
Epizyme EPZM:US 1.52M 447K
Esperion Therapeutics ESPR:US $ 33.97M 10.26M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
Karyopharm Therapeutics KPTI:US $ 3.94M 38K
Kyowa Hakko Kirin 4151:JP Y 59219M 0M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Ptc Therapeutics PTCT:US $ 15.61M 0.83M
Puma Biotechnology PBYI:US $ 7.21M 0.41M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M